Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current LiabilitiesPayablesPensionProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Daily Values
Growth Metrics
Income Statement
Others
Ratios

British American Tobacco p.l.c (BTI) Cash & Equivalents (2016 - 2025)

British American Tobacco p.l.c's Cash & Equivalents history spans 10 years, with the latest figure at $5.1 billion for Q4 2025.

  • For Q4 2025, Cash & Equivalents fell 25.12% year-over-year to $5.1 billion; the TTM value through Dec 2025 reached $5.1 billion, down 25.12%, while the annual FY2025 figure was $5.1 billion, 25.12% down from the prior year.
  • Cash & Equivalents reached $5.1 billion in Q4 2025 per BTI's latest filing, down from $6.8 billion in the prior quarter.
  • In the past five years, Cash & Equivalents ranged from a high of $6.8 billion in Q4 2024 to a low of $3.8 billion in Q4 2021.
  • Average Cash & Equivalents over 5 years is $5.1 billion, with a median of $5.1 billion recorded in 2025.
  • Peak YoY movement for Cash & Equivalents: skyrocketed 43.06% in 2023, then fell 25.12% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $3.8 billion in 2021, then rose by 6.74% to $4.0 billion in 2022, then surged by 43.06% to $5.8 billion in 2023, then grew by 17.57% to $6.8 billion in 2024, then dropped by 25.12% to $5.1 billion in 2025.
  • Per Business Quant, the three most recent readings for BTI's Cash & Equivalents are $5.1 billion (Q4 2025), $6.8 billion (Q4 2024), and $5.8 billion (Q4 2023).